CAR-T Cell therapy Lymphoma

Chimeric antigen receptor T (CAR-T) cells are immune cells that have been genetically engineered in a laboratory to display an artificial T cell receptor enabling them to target a specified protein more effectively. CAR-T cell therapy can be used to treat lymphoma by engineering cells attracted to the antigens, specific molecules expressed on lymphoma cells.

What's Popular in CAR-T Cell therapy Lymphoma

Trending News

FEB 15, 2024

Immunology

New Approach Found to Reduce Toxicity in Immunotherapy

There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi ...

Written By: Brian G. Morreale

4

FEB 08, 2024

Immunology

Engineered Immune Cells Improves Metabolic Function

Summary: Engineered immune cells, known as T cells, were found to eliminate anti-immune cells connected to age-associate ...

Written By: Brian G. Morreale

4

DEC 14, 2023

Immunology

Engineered Immune Cell Therapy Reduces Toxicity in Clinical 1 Trial

A novel immune cell therapy known as Chimeric Antigen Receptor (CAR) T cell therapy has recently demonstrated efficacy i ...

Written By: Brian G. Morreale

5

NOV 29, 2023

Cancer

CAR-T Revolution: Developing T Cells into Cancer Assassins

The CAR-T Revolution: Developing T Cells into Cancer Assassins Cancer has long been a formidable foe, but recent ...

Sponsored By: Sartorius

4

OCT 17, 2023

Cancer

CAR-NK Therapy: An Effective Strategy for Cancer Treatment

Introduction CAR-T therapies represent a new successful strategy for the treatment of hematological malignancies; howeve ...

Sponsored By: Sino Biological

6

FEB 15, 2024

Immunology

New Approach Found to Reduce Toxicity in Immunotherapy

There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi ...

Written By: Brian G. Morreale

FEB 08, 2024

Immunology

Engineered Immune Cells Improves Metabolic Function

Summary: Engineered immune cells, known as T cells, were found to eliminate anti-immune cells connected to age-associate ...

Written By: Brian G. Morreale

DEC 14, 2023

Immunology

Engineered Immune Cell Therapy Reduces Toxicity in Clinical 1 Trial

A novel immune cell therapy known as Chimeric Antigen Receptor (CAR) T cell therapy has recently demonstrated efficacy i ...

Written By: Brian G. Morreale

NOV 29, 2023

Cancer

CAR-T Revolution: Developing T Cells into Cancer Assassins

The CAR-T Revolution: Developing T Cells into Cancer Assassins Cancer has long been a formidable foe, but recent ...

Sponsored By: Sartorius

OCT 17, 2023

Cancer

CAR-NK Therapy: An Effective Strategy for Cancer Treatment

Introduction CAR-T therapies represent a new successful strategy for the treatment of hematological malignancies; howeve ...

Sponsored By: Sino Biological

JUL 05, 2023

Cell & Molecular Biology

Powering Cell & Gene Therapy with Advanced Flow Cytometry

What are cell and gene therapies? Cell and gene therapies are used to treat, and sometimes cure, diseases by addressing ...

Sponsored By: Sartorius

JAN 03, 2023

Immunology

An Antibody 'Decoy' Could Pave the Way for Better Immunotherapy

Immunotherapy called CAR T cell therapy is a treatment that aims to train immune cells to get better at fighting disease ...

Written By: Carmen Leitch

JUL 11, 2022

Cancer

Boosting CAR T Cell Therapy with TIGIT Blockade

Chimeric antigen receptor (CAR) T Cell therapy has emerged as a promising immunotherapeutic approach to treat blood canc ...

Written By: Katie Kokolus

JUN 30, 2022

Cancer

Differences between Hodgkin and non-Hodgkin Lymphoma

Lymphoma, broadly, describes a type of cancer that develops in the lymph system, a complex network made up of organs, no ...

Written By: Katie Kokolus

See More
CAR-T Cell therapy Lymphoma
Trending News

See All

Webinars

NOV 07, 2023 | 10:00 AM

Understanding the Mechanisms of Resistance in CAR T Immunotherapy...

In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...

Speaker: Marco Ruella

Sponsored By: Beckman Coulter Life Sciences

22

JUN 02, 2021 | 12:00 PM

Understand the resistance mechanims of CAR T cell therapy

Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy (CART19) occurs in 10% to 20% of patients with acute lymphoblastic leukemia (ALL); however, the mechanisms of thi...

Speaker: Yong Gu Lee Ph.D

Presented at: Immuno-Oncology Virtual Event Series 2021
Sponsored By: PerkinElmer

1

SEP 23, 2020 | 12:00 PM

Mass Cytometry in Translational Research: Session II

B cells and tertiary lymphoid structures (TLS) promote immunotherapy response 1:00–1:30 pm PDT Presented By: Rafet Basar, MD...

Speaker: Handan Xiang, PhD , Pei-Yu Chen, PhD , Hiranmayi Ravichandran, MS , Rafet Basar, MD , Amir Horowitz, PhD

Presented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit

2

OCT 05, 2016 | 10:30 AM

Immunotherapy of Cancer Using Genetically-Enhanced T Cells

The immune system possesses significant cytotoxic potential. Stimulating natural immunity through vaccination has shown promising effects in some cancers; however, a number of barriers limit...

Speaker: Michael Milone, PhD

Presented at: Cancer Research & Oncology Week Virtual Event Series 2016

2

NOV 07, 2023 | 10:00 AM

Understanding the Mechanisms of Resistance in CAR T Immunotherapy...

In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...

Speaker: Marco Ruella

Sponsored By: Beckman Coulter Life Sciences

JUN 02, 2021 | 12:00 PM

Understand the resistance mechanims of CAR T cell therapy

Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy (CART19) occurs in 10% to 20% of patients with acute lymphoblastic leukemia (ALL); however, the mechanisms of thi...

Speaker: Yong Gu Lee Ph.D

Presented at: Immuno-Oncology Virtual Event Series 2021
Sponsored By: PerkinElmer

SEP 23, 2020 | 12:00 PM

Mass Cytometry in Translational Research: Session II

B cells and tertiary lymphoid structures (TLS) promote immunotherapy response 1:00–1:30 pm PDT Presented By: Rafet Basar, MD...

Speaker: Handan Xiang, PhD , Pei-Yu Chen, PhD , Hiranmayi Ravichandran, MS , Rafet Basar, MD , Amir Horowitz, PhD

Presented at: 9th Annual Fluidigm Mass Cytometry Virtual Summit

OCT 05, 2016 | 10:30 AM

Immunotherapy of Cancer Using Genetically-Enhanced T Cells

The immune system possesses significant cytotoxic potential. Stimulating natural immunity through vaccination has shown promising effects in some cancers; however, a number of barriers limit...

Speaker: Michael Milone, PhD

Presented at: Cancer Research & Oncology Week Virtual Event Series 2016

See More
CAR-T Cell therapy Lymphoma
Webinars

Virtual Events

OCT 06, 2021 | 5:30 AM PDT

Cancer Research & Oncology Week Virtual Event Series 2021

Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...

25 2

JUN 02, 2021 | 5:30 AM PDT

Immuno-Oncology Virtual Event Series 2021

Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...

45 12

April 20 - 22, 2021 05:30 am

C.E. CREDITS

Genetics Week Virtual Event Series 2021

Labroots is excited to announce our 9th Annual Event in the Genetics Week Virtual Event Series held on April 20-22, 2021! Genetics Week Virtual Event Series 2021 will offer a multi-day...

51 8

SEP 29, 2020 | 8:00 AM PDT

2nd Annual PAWS FOR A CURE Research Symposium

2nd ANNUAL PAWS FOR A CURE VIRTUAL EVENT RESEARCH SYMPOSIUM Translational Potential Of Comparative Approaches To Accelerate Drug Development In Shared Childhood & Canine Cancers We are...

11 2

SEP 29, 2020 | 6:00 AM PDT

Applied Biosystems Genetic Analysis Virtual Conference

Due to the fact that many large events and scientific conferences have been cancelled, we want to provide you with an outlet to present your research and learn from others in our community....

28

OCT 06, 2021 | 5:30 AM PDT

Cancer Research & Oncology Week Virtual Event Series 2021

Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...

25 2

JUN 02, 2021 | 5:30 AM PDT

Immuno-Oncology Virtual Event Series 2021

Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...

45 12

April 20 - 22, 2021 05:30 am

C.E. CREDITS

Genetics Week Virtual Event Series 2021

Labroots is excited to announce our 9th Annual Event in the Genetics Week Virtual Event Series held on April 20-22, 2021! Genetics Week Virtual Event Series 2021 will offer a multi-day...

51 8

SEP 29, 2020 | 8:00 AM PDT

2nd Annual PAWS FOR A CURE Research Symposium

2nd ANNUAL PAWS FOR A CURE VIRTUAL EVENT RESEARCH SYMPOSIUM Translational Potential Of Comparative Approaches To Accelerate Drug Development In Shared Childhood & Canine Cancers We are...

11 2

SEP 29, 2020 | 6:00 AM PDT

Applied Biosystems Genetic Analysis Virtual Conference

Due to the fact that many large events and scientific conferences have been cancelled, we want to provide you with an outlet to present your research and learn from others in our community....

SEP 23, 2020 | 6:00 AM PDT

9th Annual Fluidigm Mass Cytometry Virtual Summit

Please join us at the 9th Annual Fluidigm Mass Cytometry Virtual Summit This yearly international meeting of the mass cytometry community is designed for new and experienced users, as well a...

JUN 03, 2020 | 5:30 AM PDT

Immuno-Oncology Virtual Event Series 2020

Labroots is pleased to announced the inaugural of the Immuno-Oncology Virtual Event Series taking place on June 3, 2020....

45 20

OCT 05, 2016 | 6:00 AM PDT

Cancer Research & Oncology Week Virtual Event Series 2016

The 4th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On Demand! This premier cancer research conference makes it easier...

57 5

See More
CAR-T Cell therapy Lymphoma
Virtual Events

See All